United States: FDA Publishes Action Plan For Oversight Of Artificial Intelligence/Machine Learning-Based Medical Software - Ropes & Gray LLP

On January 12, 2021, the U.S. Food and Drug Administration ("FDA") released its Artificial Intelligence/Machine Learning ("AI/ML")-Based Software as a Medical Device ("SaMD") Action Plan...